Tag: flow diversion technologies
COATING study results set to have “tremendous impact” on intracranial aneurysm...
This advertorial is sponsored by WallabyPhenox.
Ahead of the COATING study’s much-anticipated final analyses, principal investigator Laurent Pierot (Reims University Hospitals, Reims, France) sits down...
Study finds “eye-opening” variability across physician estimations of flow-diverter deployment
A comparative study recently demonstrated the promise held by PreSize Neurovascular (Oxford Heartbeat) software in consistently and accurately making predictions about flow-diverter placement in...
Continued improvement of flow diverters and intrasacculars holds key to truly...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...
Recent addition to European flow diverter market performs well in multicentre...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...
Systematic review deems coated stents plus SAPT feasible in ruptured aneurysms
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to...
Adjunctive therapy demonstrates comparable aneurysm occlusion rates to established flow diverters
The Neqstent coil-assisted flow diverter (Cerus Endovascular) has demonstrated comparable occlusion rates to those seen with other, similar flow diversion technologies, as well as...
Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal...
Fresh data from the CERUS study—the first multicentre clinical trial evaluating safety and effectiveness outcomes with the Contour neurovascular system (Cerus Endovascular)—have indicated “encouraging...
Large prospective study demonstrates high efficacy and low mortality rates with...
The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...
ESMINT 2021: COATING study “badly needed” to assess surface modification of...
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...
“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....
